CMND

About Clearmind Medicine Inc. Common Shares (CMND) Stock

Clearmind Medicine Inc. Common Shares (CMND) closed the 2026-09-18 session at $0.80, down 6.83% versus the previous close (-0.06). The stock opened at $0.85 and traded between $0.77 and $0.86 during that session. Session trading volume was 195K shares. The volume-weighted average price (VWAP) is $0.81.

Clearmind Medicine Inc is a clinical-stage pharmaceutical company engaged in Phase I/IIa clinical trials of novel psychedelic medicines. The Company focuses on developing treatments for mental health disorders, including alcohol use disorder (AUD), binge drinking, and eating disorders. Its activities are centered on the research and development of 5-methoxy-2-aminoindane (MEAI). It operates through a single research and development segment, which is conducted in Israel.

Clearmind Medicine Inc. Common Shares has a market capitalization of $2.9 million. CMND is listed on the XNAS exchange. The company employs approximately 2 people. The recorded listing date is 2021-08-10.

On this page you can find market CMND stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.